MOACM
INSY

Mutual of America Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Mutual of America Capital Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-870
Closed -$25K – 1246
2015
Q4 		$25K Hold
870
– – ﹤0.01% 1223
2015
Q3 		$25K Hold
870
– – ﹤0.01% 1235
2015
Q2 		$31K Sell
870
-400
-31% -$12.5K ﹤0.01% 1228
2015
Q1 		$37K Hold
1,270
– – ﹤0.01% 1211
2014
Q4 		$27K Sell
1,270
-250
-16% -$4.94K ﹤0.01% 1231
2014
Q3 		$29K Buy
+1,520
New +$23.9K ﹤0.01% 1234

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mutual of America Capital Management's INSY Position: Q1 2016 in Review

Mutual of America Capital Management sold out of Insys Therapeutics, Inc. (INSY) in Q1 2016, closing a stake of 870 shares — an estimated $25K sold.

Mutual of America Capital Management first reported a position in INSY in Q3 2014 and held it in 6 quarters. The position peaked at $37K in Q1 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q1 2016.

  • Mutual of America Capital Management reported no remaining Insys Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Mutual of America Capital Management sold 870 Insys Therapeutics, Inc. shares in Q1 2016, an estimated $25K.
  • Mutual of America Capital Management first reported a position in Insys Therapeutics, Inc. in Q3 2014 and held it in 6 quarters.
  • Mutual of America Capital Management's Insys Therapeutics, Inc. position peaked at $37K in Q1 2015.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2016.

Based on Mutual of America Capital Management's 13F filing for Q1 2016, filed 10 May 2016.